New combo therapy shows promise for rare penile cancer
NCT ID NCT06353906
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tests a combination of chemotherapy (carboplatin and paclitaxel) plus an immunotherapy drug (pembrolizumab) in 27 men with advanced penile cancer that has spread to lymph nodes. The goal is to see if this treatment can completely eliminate the cancer before surgery. Participants will receive the drugs first, then have surgery to remove any remaining cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROGENITAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NKI-AVL
RECRUITINGAmsterdam, North Holland, 1066CX, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UZ Leuven
RECRUITINGLeuven, 3000, Belgium
Contact
Conditions
Explore the condition pages connected to this study.